Daniel Goldstein, MBBS

Director, Center for the Biology of Aging and Cardiovascular Diseases

Research Interests

Aging; Cardiology; Immune System; Immunity; Inflammation; Transplantation; Organ Transplantation

Research Organizations


Immunology and Immunotherapy

Internal Medicine: Rheumatic Diseases Research Core | Yale Cardiovascular Research Center

Vascular Biology and Therapeutics Program

Office of Cooperative Research

Research Summary

We are primarily interested in how inflammation impacts organ transplantation, and how aging alters acute and chronic inflammation to enhance disease.

Specialized Terms: Immunity in transplantation; Impact of aging on inflammation and immunity

Extensive Research Description

As a transplant physician, I have investigated the mechanisms and consequences of innate immune activation after organ transplantation. My laboratory was the first to demonstrate that Toll like receptor signaling via MyD88 accelerated the tempo of acute transplant rejection (JCI, 2003, AJT, 2004) and impaired transplant tolerance (JI, 2006, JASN, 2008). These were some of the first studies to show that Toll like receptors activate inflammation in sterile in vivo models. The activators of the innate immune system after transplantation have remained elusive. We recently discovered that haptoglobin stimulates innate immunity to induce inflammation after organ transplantation (JCI, 2012). As a result of our work some laboratories and pharmaceutical companies are targeting innate immune pathways to reduce inflammation after organ transplantation.

I am also interested in how aging impacts immunity, initially to determine if older transplant recipients exhibit altered immune responses to transplantation. My laboratory challenged the paradigm that declining immune function is responsible for age-associated disorders. In murine viral infection models, we determined that exaggerated IL-17 production by NKT cells induces lethal immune pathology (Cell Host and Microbe, 2009). In murine vascular models, we demonstrated that elevatedinflammatory responses by vascular smooth muscle cells may predispose to atherosclerosis (ATVB, 2012). Finally, in murine transplant models we documented that enhanced responses by naïve CD8+ T cells may impair immune tolerance with aging (JI, 2011). In sum, we have made innovative findings, challenging current paradigms, that elevated immune responses explain age-associated phenotypes.

1) Organ Transplantation

  • How inflammation impacts organ transplantation
    • Identifying inflammatory triggers that induce acute organ transplant rejection in experimental skin and heart transplant using non-biased approaches such as proteomics. The impact of this work is that it may identify novel targets to reduce intra-graft inflammation to improve outcomes after organ transplantation.
    • Employing nanoparticles to enhance allograft survival in experimental skin and heart transplant models. The impact of this work is that is may elucidate a novel platform to deliver immune suppressants to organ transplant recipients and avoid the side-effects of these medications.
    • How aging impacts immune regulation to organ transplants. We are employing experimental models of organ transplant to elucidate novel age-specific pathways by which aging impacts the immune response to organ transplantation. The impact of this work is that it may reveal novel therapeutics to improve the efficacy of organ transplantation to older recipients, the largest pool of patients that are receiving organ transplants.

2) Aging and Inflammation

  • How aging impacts the acute innate immune response to primary influenza viral infection. The impact of this work is that it may reveal novel pathways and hence therapies by which aging leads to morbidity and mortality after influenza viral lung infection.
  • How aging impacts chronic inflammation to enhance atherosclerosis. We are employing murine experimental models to understand how aging leads to enhanced atherosclerosis. The impact of this work is that it may lead to novel therapies to reduce the impact of atherosclerosis with aging.

Selected Publications

Edit this profile

Contact Info

Daniel Goldstein, MBBS
Patient Care Locations
Yale Congestive Heart FailureYale Physicians Building
800 Howard Avenue, Ste 2nd floor

New Haven, CT 06519
View on map...
Yale CardiologyLaboratory for Medicine and Pediatrics (LMP)
15 York Street

New Haven, CT 06510
View on map...
Office Location
The Anlyan Center
300 Cedar Street

New Haven, CT 06519
View on map...
Mailing Address
PO Box 208056
333 Cedar Street

New Haven, CT 06520-8056

Curriculum Vitae